1 INTRODUCTION 14
1.1 STUDY OBJECTIVES 14
1.2 MARKET DEFINITION 14
1.2.1 INCLUSIONS AND EXCLUSIONS 14
1.3 STUDY SCOPE 15
1.4 YEARS CONSIDERED 15
1.5 CURRENCY CONSIDERED 16
1.6 LIMITATIONS 16
1.7 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
FIGURE 1 RESEARCH DESIGN 17
2.1.1 SECONDARY DATA 18
2.1.2 PRIMARY DATA 19
FIGURE 2 BREAKDOWN OF PRIMARIES: ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET 19
2.2 MARKET ESTIMATION METHODOLOGY 20
FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION) 20
FIGURE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SIZE (USD MILLION) 20
FIGURE 5 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: FINAL CAGR PROJECTIONS (2022−2027) 21
FIGURE 6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 21
2.3 MARKET DATA ESTIMATION AND TRIANGULATION 22
FIGURE 7 DATA TRIANGULATION METHODOLOGY 22
2.4 INDUSTRY INSIGHTS 23
2.5 RESEARCH ASSUMPTIONS 23
3 EXECUTIVE SUMMARY 24
FIGURE 8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 24
FIGURE 9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION) 25
FIGURE 10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 25
FIGURE 11 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 26
FIGURE 12 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY COUNTRY, 2021 27
4 PREMIUM INSIGHTS 28
4.1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET OVERVIEW 28
FIGURE 13 REDUCED COST OF NEXT-GENERATION SEQUENCING TO DRIVE MARKET GROWTH 28
4.2 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY PRODUCT (2021) 29
FIGURE 14 CONSUMABLES SEGMENT DOMINATED MARKET IN JAPAN 29
4.3 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION (2021) 29
FIGURE 15 TRANSLATIONAL RESEARCH SEGMENT DOMINATED MARKET IN CHINA 29
5 MARKET OVERVIEW 30
5.1 INTRODUCTION 30
5.2 MARKET DYNAMICS 30
FIGURE 16 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 30
TABLE 1 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS 31
5.2.1 DRIVERS 31
5.2.1.1 Reduced cost of next-generation sequencing 31
5.2.1.2 Increasing adoption of spatial genomics and transcriptomics in drug discovery and development 32
5.2.2 RESTRAINTS 32
5.2.2.1 High capital investments 32
5.2.3 OPPORTUNITIES 32
5.2.3.1 Increasing demand for single-cell analysis 32
5.2.4 CHALLENGES 33
5.2.4.1 Analytical limitations associated with spatial techniques 33
5.3 TECHNOLOGY ANALYSIS 33
TABLE 2 FIVE BENCHMARK COMPUTATIONAL METHODS: COMPARATIVE ANALYSIS 34
5.4 VALUE CHAIN ANALYSIS 35
TABLE 3 INDICATIVE LIST OF DISTRIBUTORS FOR KEY MARKET PLAYERS IN ASIA PACIFIC 35
FIGURE 17 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS 36
5.5 ECOSYSTEM ANALYSIS 36
FIGURE 18 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS 37
5.6 PORTER’S FIVE FORCES ANALYSIS 37
TABLE 4 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS 37
5.6.1 THREAT OF NEW ENTRANTS 37
5.6.2 THREAT OF SUBSTITUTES 37
5.6.3 BARGAINING POWER OF BUYERS 38
5.6.4 BARGAINING POWER OF SUPPLIERS 38
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 38
5.7 REGULATORY ANALYSIS 38
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 38
TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 38
5.8 PRICING ANALYSIS 39
TABLE 6 PRODUCT PRICING: KEY MARKET PLAYERS 39
5.8.1 AVERAGE SELLING PRICE TREND 39
5.9 KEY CONFERENCES AND EVENTS (2020–2023) 39
TABLE 7 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2020–2023) 39
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 40
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 40
FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 40
5.10.2 BUYING CRITERIA FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET IN ASIA PACIFIC REGION 40
FIGURE 20 KEY BUYING CRITERIA FOR END USERS 40
6 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY PRODUCT 41
6.1 INTRODUCTION 42
TABLE 8 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 42
6.2 CONSUMABLES 42
6.2.1 GROWING USE OF CONSUMABLES FOR VARIOUS SPATIAL GENOMICS AND TRANSCRIPTOMICS APPLICATIONS TO DRIVE GROWTH 42
TABLE 9 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 43
6.3 INSTRUMENTS 43
6.3.1 INTRODUCTION OF NOVEL INSTRUMENTS TO DRIVE MARKET 43
TABLE 10 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 44
6.4 SOFTWARE 44
6.4.1 RISING USE OF SPATIAL OMICS FOR DISEASE DIAGNOSIS TO PROPEL DEMAND FOR SOFTWARE 44
TABLE 11 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 45
7 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE 46
7.1 INTRODUCTION 47
TABLE 12 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 47
7.2 SPATIAL TRANSCRIPTOMICS 47
TABLE 13 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 47
TABLE 14 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 48
7.2.1 IMMUNOHISTOCHEMISTRY 48
7.2.1.1 Emergence of mIHC/IF to propel growth 48
TABLE 15 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 49
7.2.2 IN SITU HYBRIDIZATION 49
7.2.2.1 High adoption of MERFISH to drive growth 49
TABLE 16 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 50
7.2.3 SPATIAL TRANSCRIPTOMIC SEQUENCING 50
TABLE 17 ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 50
7.2.3.1 Microdissection-based sequencing 51
7.2.3.1.1 Increasing use of microdissection-based sequencing to contribute to market growth 51
TABLE 18 ASIA PACIFIC: MICRODISSECTION-BASED SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 51
7.2.3.2 In situ sequencing 52
7.2.3.2.1 Increased adoption of in situ sequencing likely to boost market growth 52
TABLE 19 ASIA PACIFIC: IN SITU SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 52
7.2.3.3 Other sequencing technologies 53
TABLE 20 ASIA PACIFIC: SPATIAL TRANSCRIPTOMIC SEQUENCING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020–2027 (USD MILLION) 53
7.2.4 MICROSCOPY-BASED RNA IMAGING 53
7.2.4.1 Increasing use of microscopy-based RNA imaging in cancer research and diagnosis to drive growth 53
TABLE 21 ASIA PACIFIC: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 54
7.2.5 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES 54
TABLE 22 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020–2027 (USD MILLION) 54
7.3 SPATIAL GENOMICS ANALYSIS 55
TABLE 23 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 55
TABLE 24 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 55
7.3.1 FLUORESCENCE IN SITU HYBRIDIZATION 56
7.3.1.1 Emerging potential of spatial genomics analysis in cancer diagnostics to support growth 56
TABLE 25 ASIA PACIFIC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 56
7.3.2 SPATIAL GENOMIC SEQUENCING 56
7.3.2.1 Rising adoption of massively parallel sequencing to drive growth 56
TABLE 26 ASIA PACIFIC: SPATIAL GENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 57
7.3.3 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES 57
TABLE 27 ASIA PACIFIC: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 57
8 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY APPLICATION 58
8.1 INTRODUCTION 59
TABLE 28 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59
8.2 TRANSLATIONAL RESEARCH 59
8.2.1 DEMAND FOR SPATIAL TRANSCRIPTOMICS IN UNDERSTANDING TUMOR MICROENVIRONMENT TO DRIVE GROWTH 59
TABLE 29 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 60
8.3 DRUG DISCOVERY AND DEVELOPMENT 60
8.3.1 RISING USE OF RNA-SEQ IN DRUG DISCOVERY TO DRIVE GROWTH 60
TABLE 30 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 61
9 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY END USER 62
9.1 INTRODUCTION 63
TABLE 31 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 63
9.2 ACADEMIC AND RESEARCH INSTITUTES 63
9.2.1 INCREASING DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS IN TRANSLATIONAL RESEARCH TO DRIVE GROWTH 63
TABLE 32 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 64
9.3 CONTRACT RESEARCH ORGANIZATIONS 64
9.3.1 INCREASING NUMBER OF CROS FORMING STRATEGIC PARTNERSHIPS WITH GENOMICS PROVIDERS TO DRIVE GROWTH 64
TABLE 33 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 65
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 65
9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS SYSTEMS 65
TABLE 34 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 66
10 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET,
BY COUNTRY 67
10.1 INTRODUCTION 68
TABLE 35 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 68
10.2 CHINA 68
10.2.1 INCREASING R&D SPENDING BY GOVERNMENT AND BIOPHARMA COMPANIES TO SUPPORT MARKET GROWTH 68
TABLE 36 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 69
TABLE 37 CHINA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 69
TABLE 38 CHINA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 69
TABLE 39 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 70
TABLE 40 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70
TABLE 41 CHINA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 70
10.3 JAPAN 71
10.3.1 RISING FUNDING IN JAPAN TO BOOST RESEARCH APPLICATIONS 71
TABLE 42 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 71
TABLE 43 JAPAN: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 71
TABLE 44 JAPAN: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 72
TABLE 45 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 72
TABLE 46 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 72
TABLE 47 JAPAN: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 73
10.4 INDIA 73
10.4.1 COLLABORATIONS BETWEEN HOSPITALS AND DIAGNOSTIC CENTERS FOR LABORATORY SERVICES TO BOOST GROWTH 73
TABLE 48 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 73
TABLE 49 INDIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 74
TABLE 50 INDIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 74
TABLE 51 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 74
TABLE 52 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 75
TABLE 53 INDIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 75
10.4.2 SINGAPORE 75
10.4.2.1 Active partnerships with key players to boost market growth 75
TABLE 54 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 76
TABLE 55 SINGAPORE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 76
TABLE 56 SINGAPORE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 77
TABLE 57 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 77
TABLE 58 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 77
TABLE 59 SINGAPORE: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 78
10.4.3 SOUTH KOREA 78
10.4.3.1 Government initiatives and strong R&D expenditure to propel demand for spatial solutions 78
TABLE 60 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 78
TABLE 61 SOUTH KOREA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 79
TABLE 62 SOUTH KOREA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 79
TABLE 63 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 80
TABLE 64 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 80
TABLE 65 SOUTH KOREA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 80
10.4.4 AUSTRALIA 81
10.4.4.1 Increasing adoption of spatial solutions by research institutions to propel growth 81
TABLE 66 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 81
TABLE 67 AUSTRALIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 82
TABLE 68 AUSTRALIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 82
TABLE 69 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 83
TABLE 70 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83
TABLE 71 AUSTRALIA: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 83
10.4.5 REST OF ASIA PACIFIC 84
TABLE 72 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 84
TABLE 73 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 84
TABLE 74 REST OF ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 85
TABLE 75 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 85
TABLE 76 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 85
TABLE 77 REST OF ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 86
11 COMPETITIVE LANDSCAPE 87
11.1 INTRODUCTION 87
11.2 RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS 87
FIGURE 21 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 88
11.3 REVENUE SHARE ANALYSIS (TOP SIX PLAYERS) 89
11.4 MARKET SHARE ANALYSIS (2021) 89
11.5 COMPANY EVALUATION MATRIX 91
11.5.1 STARS 91
11.5.2 EMERGING LEADERS 91
11.5.3 PERVASIVE PLAYERS 91
11.5.4 PARTICIPANTS 91
FIGURE 24 SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (2021) 92
11.6 COMPETITIVE SCENARIO AND TRENDS 93
11.6.1 DEALS 93
TABLE 78 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: DEALS 93
11.6.1.1 Product launches 94
TABLE 79 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES 94
11.6.1.2 Other developments 94
TABLE 80 ASIA PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET: OTHER DEVELOPMENTS 94
12 COMPANY PROFILES 95
12.1 KEY PLAYERS 95
(Business Overview, Products, Recent Developments, MnM View)*
12.1.1 NANOSTRING 95
TABLE 81 NANOSTRING: BUSINESS OVERVIEW 95
FIGURE 25 NANOSTRING: COMPANY SNAPSHOT (2021) 96
12.1.2 10X GENOMICS 101
TABLE 82 10X GENOMICS: BUSINESS OVERVIEW 101
FIGURE 26 10X GENOMICS: COMPANY SNAPSHOT (2021) 102
12.1.3 ILLUMINA 105
TABLE 83 ILLUMINA: BUSINESS OVERVIEW 105
FIGURE 27 ILLUMINA: COMPANY SNAPSHOT (2021) 106
12.1.4 BIO-RAD LABORATORIES, INC. 111
TABLE 84 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 111
FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021) 112
12.1.5 BIO-TECHNE 114
TABLE 85 BIO-TECHNE: BUSINESS OVERVIEW 114
FIGURE 29 BIO-TECHNE: COMPANY SNAPSHOT (2021) 115
12.1.6 STANDARD BIOTOOLS 120
TABLE 86 STANDARD BIOTOOLS: BUSINESS OVERVIEW 120
FIGURE 30 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2021) 121
12.1.7 AKOYA BIOSCIENCES 127
TABLE 87 AKOYA BIOSCIENCES: BUSINESS OVERVIEW 127
FIGURE 31 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2021) 127
12.1.8 S2 GENOMICS 131
TABLE 88 S2 GENOMICS: BUSINESS OVERVIEW 131
12.1.9 CANTATA BIO 132
TABLE 89 CANTATA BIO: BUSINESS OVERVIEW 132
12.1.10 VIZGEN CORP. 133
TABLE 90 VIZGEN: BUSINESS OVERVIEW 133
*Details on Business Overview, Products, Recent Developments, MnM View might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 134
12.2.1 BGI GROUP 134
12.2.2 MILTENYI BIOTEC 134
12.2.3 BRUKER 135
12.2.4 PERKINELMER INC. 135
12.2.5 NOVOGENE CO., LTD. 136
13 APPENDIX 137
13.1 DISCUSSION GUIDE 137
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 140
13.3 CUSTOMIZATION OPTIONS 142
13.4 RELATED REPORTS 142
13.5 AUTHOR DETAILS 143
| ※参考情報 空間ゲノミクスとトランスクリプトミクスは、細胞や組織内での遺伝子の発現や構造を、空間的な情報とともに解析する先端的な研究分野です。これらの手法は主に、病理学や生物学、医学研究などでの応用が期待されています。特に、アジア太平洋地域（APAC）では、これらの技術が急速に発展し、多くの研究機関や企業がその可能性を探っています。 空間ゲノミクスは、細胞や組織におけるDNAの配列や遺伝子の配置を空間的に可視化する手法です。この技術によって、特定の遺伝子がどこに存在するのか、またその発現レベルがどう変化するのかを理解することができます。例えば、腫瘍組織内の異なる細胞群の遺伝子発現パターンを把握することで、腫瘍の進行状況や治療効果を評価することが可能になります。 一方でトランスクリプトミクスは、RNAの発現を定量的に測定する手法です。特に空間トランスクリプトミクスは、発現されるRNA分子の位置情報を保持しつつ、その量を測定することができる技術です。これにより、異なる組織や細胞間の発現パターンの違いや、特定の環境における遺伝子応答を明らかにすることができます。 空間ゲノミクスとトランスクリプトミクスの技術は、いくつかの種類に分類されます。一般に使用される方法には、マイクロアレイ、RNA-Seq、イメージング技術などがあります。特に、現在はハイスループットのシーケンシング技術が普及し、これにより大量のデータを生成し、高精度で分析することが可能になっています。また、画像解析ソフトウェアや機械学習技術を組み合わせることで、解析精度や効率が向上しています。 これらの技術の用途は多岐にわたります。例えば、がん治療の分野では、腫瘍微小環境の理解に利用され、異なる細胞タイプの相互作用や、がん細胞の逃避機構を探る研究が行われています。また、神経科学においても、特定の神経細胞群の発現パターンを研究することで、脳機能や神経疾患の理解が進められています。 空間ゲノミクスやトランスクリプトミクスの関連技術には、画像解析技術、データ解析ソフトウェア、バイオインフォマティクスツールなどがあります。これらは大量のデータを処理・解析するために必要不可欠です。同時に、これらのデータを可視化し、理解しやすい形で提示するための技術も重要です。 アジア太平洋地域では、政府や研究機関が協力してこれらの技術の開発を進めており、多くの国々で新たな研究が活発に行われています。特に日本や中国、韓国などの国々では、空間ゲノミクスとトランスクリプトミクスの研究が進んでおり、国際的な共同研究や学会も盛況です。これにより、最新の技術や知見が迅速に共有され、分野全体の進歩が促進されています。 今後、この分野ではさらなる技術革新が期待されており、高解像度での解析手法や、リアルタイムでの観察技術の開発が進むことで、より詳細な生物学的なメカニズムの理解が進むでしょう。特に、パーソナライズド医療や再生医療においても、空間ゲノミクスやトランスクリプトミクスの成果が応用されることで、効果的な治療法の開発が期待されています。 このように、空間ゲノミクスとトランスクリプトミクスは、生物学や医学の分野において重要な役割を果たしており、今後の研究の進展が非常に楽しみです。アジア太平洋地域においても、その発展が期待される分野であり、多くの可能性に満ちています。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
